Fortress Biotech, Inc.FBIONASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank73
3Y CAGR-11.6%
5Y CAGR+7.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-11.6%/yr
vs +49.7%/yr prior
5Y CAGR
+7.8%/yr
Recent deceleration
Acceleration
-61.3pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.29M | +2.0% |
| 2024 | $20.88M | -8.8% |
| 2023 | $22.89M | -25.6% |
| 2022 | $30.77M | -4.1% |
| 2021 | $32.08M | +119.8% |
| 2020 | $14.59M | +38.6% |
| 2019 | $10.53M | +72.0% |
| 2018 | $6.13M | -96.2% |
| 2017 | $161.20M | +1320.4% |
| 2016 | $11.35M | - |